SEC Form 4
YD Bio Limited (YDES) insider trading
In the 12 months to Oct 26, 2026, one YDES insider reported open-market purchases of $128.5K across 3 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $128.5K
- 3 filings · Ethan PhD Shen, CEO
Who traded YDES, and when
- Purchase
YDES daily close from Oct 27, 2025 to Oct 26, 2026, between $1.90 and $17.11, last $5.27. 0 sale and 3 purchase filings by 1 insider, marked at their filing dates. Ethan PhD Shen, CEO: bought $128.5K across 3 filings, first filed Sep 8, 2026, last Sep 16, 2026.
Largest mark · tap a row for others
Ethan PhD Shen · CEO
Filing 1 of 2 within a week · $79,630 total
Purchase $67,447
18,378 shares
Filed Sep 8, 2026 · traded Sep 4
Close on filing date $4.25
Ethan PhD Shen · CEO
CEO
$128.5K boughtOpen-market trades
3 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Ethan PhD Shen | CEO | — | $128.5K | 3 | — |
| Filed | Insider | Type | Shares | Value | Held after | Source |
|---|---|---|---|---|---|---|
traded | Ethan PhD Shen CEO | Purchase | 12,700 ordinary shares | $48.9K | 11,258,331 | |
traded | Ethan PhD Shen CEO | Purchase | 3,100 ordinary shares | $12.2K | 11,245,631 | |
traded | Ethan PhD Shen CEO | Purchase | 18,378 ordinary shares | $67.4K | 11,242,531 |
Shares are as filed (ordinary shares or ADS); values are as converted to US$ in the filing.
GET /stocks/filings/vX/form-4?tickers=YDES&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"YDES",
"YDESW"
],
"issuer_cik": "0002011674",
"owner_cik": "0002099921",
"accession_number": "0001213900-26-100506",
"form_type": "4",
"filing_date": "2026-09-16",
"period_of_report": "2026-09-14",
"issuer_name": "YD Bio Ltd",
"issuer_trading_symbol": "YDES",
"owner_name": "Shen Ethan PhD",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Ordinary Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-14",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 12700,
"transaction_price_per_share": 3.85,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 11258331,
"transaction_value": 48895,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.67 to $3.97, inclusive. The reporting person undertakes to provide to YD Bio Ltd (the \"Company\"), any security holder of the Company or the staff of the U.S. Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of Ordinary Shares purchased at each separate price within the range set forth above."
}
]
},
{
"tickers": [
"YDES",
"YDESW"
],
"issuer_cik": "0002011674",
"owner_cik": "0002099921",
"accession_number": "0001213900-26-098775",
"form_type": "4",
"filing_date": "2026-09-10",
"period_of_report": "2026-09-09",
"issuer_name": "YD Bio Ltd",
"issuer_trading_symbol": "YDES",
"owner_name": "Shen Ethan PhD",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Ordinary Shares",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-09",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 3100,
"transaction_price_per_share": 3.93,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 11245631,
"transaction_value": 12183,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.80 to $4.09, inclusive. The reporting person undertakes to provide to YD Bio Ltd (the \"Company\"), any security holder of the Company or the staff of the U.S. Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of Ordinary Shares purchased at each separate price within the range set forth above."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 6 records
- Option exercises6 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has YD Bio Limited's CEO sold stock?
No. Ethan PhD Shen (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is YDES’s insider data?
These are YDES Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track YDES insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for YDES every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.